Background: Preeclampsia is clinically defined by hypertension and proteinuria, with or without pathological edema. Preeclampsia is a multisystem disorder that complicates about 4%-18% of pregnancies in developing nations and constitutes a major source of morbidity and mortality worldwide. Preeclampsia may be life-threatening for both mother and child, increasing both fetal and maternal morbidity and mortality. About 10%-15% of maternal deaths are directly associated with preeclampsia. Objective: To compare the changes in the level of serum calcium, serum magnesium, and serum electrolytes in patients with preeclampsia and normal pregnant women. Material and Method: Serum calcium, serum magnesium, and serum electrolytes were estimated in 50 cases of preeclampsia and 50 controls of normal pregnant women. 5 ml of blood was collected with clot activator vaccutte and assayed on Micro lab Rx- 50V Biochemistry Analyzer. Result: The levels of serum calcium, serum magnesium, and serum electrolytes are found to be decreased in pre-eclamptic patients (p<0.001) as compared to normal pregnant women. Serum calcium levels were found to decrease in pre-eclamptic patients (7.624 ± 0.84) as compared to normal pregnant women (8.52 ± 0.80). Serum magnesium levels were found to decrease in pre-eclamptic patients (1.47 ± 0.25) as compared to normal pregnant women (1.79 ± 0.18). Serum sodium levels were found to decrease in pre-eclamptic patients (131.46 ± 6.96) as compared to normal pregnant women (139.92 ± 7.86). Serum potassium levels were found to decrease in preeclamptic patients (3.39 ± 0.52) as compared to normal pregnant women (3.67 ± 0.38). Conclusion: We concluded that the levels of serum calcium, serum magnesium, and serum electrolytes were decreased significantly in patients with preeclampsia (p<0.001). Results also prove that these biomarkers can be used as important parameters for the diagnosis of preeclampsiaa.
Select your language of interest to view the total content in your interested language